In AML patients, NK cells also displayed reduced IL-15Rβ/CD122 expression, and although CD71 and CD98 expression was similar to controls at steady state, NK cells from patients showed a limited up-regulation of these metabolic surrogate markers upon cytokine stimulation. The gene discussed is IL2RB; the disease is acute myeloid leukemia.